Quantifying the Economic Burden of Depression

Analysis Group's landmark study on the societal costs of clinical depression, led by Managing Principal Paul Greenberg, is one of the most frequently cited health economics articles to appear in medical literature -- amassing more than 1,000 citations, according to Google Scholar. In that study, the authors determined that the annual costs of depression in the United States in 1990 were $43.7 billion. These results were later updated through 2000, and subsequently highlighted in The Wall Street Journal. The authors found that although the overall cost of treating depression did not change greatly between 1990 and 2000, many more depression sufferers received treatment as a result of successful outreach. However, the shift to less expensive medical care resulted in a lower overall quality of depression treatment. These results were updated again in 2015 and found that the economic burden of individuals in the United States suffering from major depressive disorder rose 21%, from $173.2 billion in 2005 to $210.5 billion in 2010. The study also found that the 2008 economic recession made it particularly hard for those suffering from depression to retain their jobs. The latest study was featured in several media outlets, including Scientific American and NPR.

Associated Experts & Staff